Products

Paridis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Paridis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: paridis-rhizoma-veterinary-grade-api-for-tablets-injections-capsules-powders-granules-premix-solutions
    • Einecs: 242-374-4
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    549925

    Product Name Paridis Rhizoma Veterinary Grade API
    Dosage Forms Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions
    Appearance Fine yellow-brown powder
    Main Component Total saponins of Paridis Rhizoma
    Purity ≥98% (by HPLC)
    Intended Use Active pharmaceutical ingredient for veterinary medicines
    Source Extracted from the rhizomes of Paris polyphylla and related species
    Storage Conditions Cool, dry, and sealed conditions, away from light
    Solubility Slightly soluble in water, soluble in ethanol
    Shelf Life 24 months when properly stored
    Manufacturing Standards Complies with veterinary GMP requirements
    Packing Double-layer polyethylene bags inside fiber drums
    Country Of Origin China
    Quality Control Tested for heavy metals, residual solvents, and microbial limits
    Application Used for anti-inflammatory, antitumor, and hemostatic veterinary medications

    As an accredited Paridis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Sealed in a 25kg double-layered fiber drum with inner polyethylene bag, clearly labeled for Paridis Rhizoma Veterinary Grade API use.
    Shipping **Shipping Description:** Paridis Rhizoma Veterinary Grade API is securely packed in tamper-proof, moisture-resistant containers. Shipped via express air or sea freight, with temperature and humidity control as required. All shipments include MSDS, Certificate of Analysis, and proper labeling to ensure compliance with international safety and regulatory standards. Expedited delivery available upon request.
    Storage Paridis Rhizoma Veterinary Grade API should be stored in a tightly sealed container, protected from light, moisture, and heat. Keep in a cool, dry, and well-ventilated area, ideally at temperatures below 25°C. Ensure the storage area is secure, clean, and free from incompatible substances. Follow all regulatory guidelines for proper storage and handling of veterinary pharmaceutical ingredients.
    Application of Paridis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Applications of Paridis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial Manufacturing

    Manufacturers across the veterinary pharmaceutical sector rely on our Paridis Rhizoma Veterinary Grade API for integration into finished dosage forms used in modern animal health programs. Industrial customers select this raw material for applications where high purity, consistent extract profile, and compliance with international regulations are critical to downstream formulation quality and safety. Below, we detail core application scenarios, supported by real-world manufacturing practices and regulatory demands.

    1. Cattle and Livestock Oral Tablet Manufacturing

    Major veterinary medicine producers incorporate our API in pressed oral tablets designed for livestock, addressing specific anti-inflammatory and pain management indications. Production teams standardize exact extract loads based on target animal weight and regional veterinary drug regulations. The raw material is blended with excipients, compressed, and finished under GMP controls. Formulators use this input to meet prescription requirements for ruminant markets, balancing efficacy with precise dosing and dissolution profiles required by veterinary practitioners.

    Industry compliance standards

    • China Veterinary Pharmacopoeia (2020 Edition)
    • European Pharmacopoeia 10.0 (Ph. Eur. monographs on herbal veterinary APIs)
    • Good Manufacturing Practice (GMP) for Veterinary Drugs (China, EU, ASEAN)
    • Ministry of Agriculture and Rural Affairs PRC No. 194

    Typical usage ratio

    • 3% - 12% of tablet mass, adjusted for extraction potency and per-dose veterinary prescription requirements

    Downstream process integration

    • Direct addition to granulation hopper with microcrystalline cellulose, starch, and binding agents prior to compression

    Final product types

    • Chewable anti-inflammatory tablets for cattle, sheep, and goats
    • Multi-component oral pain reliever tablets
    • Prescription-only livestock veterinary medications
    • Animal feedlot stress management supplements (tablet form)

    2. Injectable Solution for Equine and Companion Animal Use

    Our extract serves as an active component in sterile injectable veterinary preparations focused on large animal and companion animal clinical care. Regulatory departments mandate strict purification and endotoxin testing for parenteral applications, with precise solubilization and filtration procedures during formulation. Formulation scientists titrate inclusion based on pharmacokinetic data and injection site tolerability, ensuring stability and uniformity throughout shelf life. These injections are produced in high-containment cleanrooms and distributed to veterinary clinics under prescription protocols.

    Industry compliance standards

    • Veterinary Injectable Drug GMP (China Ministry of Agriculture)
    • EU Directive 2001/82/EC on Veterinary Medicinal Products
    • United States Pharmacopeia (USP) Chapter <797> for sterile compounding
    • ISO 9001:2015 Quality Management for Production

    Typical usage ratio

    • 0.5 mg – 5 mg/mL in injection solution, defined by animal species, formulation stability, and maximum residue limits (MRL) on food animals

    Downstream process integration

    • Dissolution in sterile aqueous solvent and buffer, followed by 0.22 μm sterile filtration prior to fill-finish and autoclave sterilization

    Final product types

    • Prescription injectable anti-inflammatory solutions for equine clinics
    • Emergency pain relief injections for veterinary surgeries
    • Multi-dose vial presentations for herd health management
    • Veterinary hospital use ampoules

    3. Powder Premix for Swine and Poultry Feed Integration

    Feed manufacturers use our veterinary-grade extract in powder premix for incorporation into compound feeds aimed at large-scale intensive farming. Quality assurance teams perform batch homogenization to ensure reliable delivery of the API in mechanized feed blending. Industry regulations require accurate traceability and residual analysis, particularly for animals in the food chain. Mixing engineers tailor inclusion rates to optimize animal recovery and mitigate withdrawal period risk during routine farm health programs.

    Industry compliance standards

    • GB 13078-2017 (China Feed Hygiene Standard)
    • EU Feed Additive Registry (Regulation EC No. 1831/2003)
    • FDA BSE/Ruminant Feed Ban (21 CFR 589.2000-2001)
    • HACCP Feed Safety Management Systems

    Typical usage ratio

    • 100 mg – 400 mg per kg of complete feed blend, determined by animal species, age class, and withdrawal recommendations

    Downstream process integration

    • Addition to dry feed mixer post-extrusion; uniform blending with vitamins, trace minerals, and carriers before final packaging

    Final product types

    • Medicated swine starter feed premixes
    • Poultry anti-inflammatory feed supplements
    • Complete animal feed products requiring veterinary medicinal inclusion
    • Feedlot recovery formulations for piglets and chicks

    4. Granule Formulation for Companion Animal Dietary Supplements

    Pet industry brands formulate granules containing our standardized extract for dietary use in dogs, cats, and small mammals. These products typically serve as supportive anti-inflammatory agents within functional treat or supplement product lines. Our ingredient is heat-stable and compatible with flavor masking agents, facilitating direct dosing or mixing with regular pet food. Regulatory oversight for companion animal products requires both ingredient traceability and evidence of non-toxicity at recommended usage rates, with batch records maintained across the supply chain.

    Industry compliance standards

    • AAFCO Guidelines for Animal Feed Ingredients (USA)
    • EU Regulation (EC) No. 767/2009 (Marketing and Use of Feed)
    • Pet Food Industry HACCP Programs
    • ISO 22000 Food Safety Management for Animal Feeds

    Typical usage ratio

    • 50 mg – 200 mg per granule, with adjustment for animal weight and product form; consultation with veterinary nutritionists recommended

    Downstream process integration

    • Incorporation during wet granulation stage with palatability enhancers and colorants, prior to drying and sieving

    Final product types

    • Granular oral supplements for canine joint care
    • Feline urinary tract health granules
    • Oral soft chew supplement blends
    • Veterinary channel pet supplements for chronic inflammatory support

    5. Powder Fill Capsule Production for Aquaculture Health

    Aquatic animal health companies utilize our API within powder-filled capsules for targeted dosing in high value fish and shrimp operations. Capsule manufacturing adheres to strict marine veterinary regulations, with demand for reliable batch consistency and in-process contamination controls. Production lines optimize capsule payload to animal weight and anticipated water dilution, ensuring targeted delivery during breeding, disease outbreaks, or rehabilitation. Process managers validate capsule content and shell interaction under accelerated shelf-life studies.

    Industry compliance standards

    • FAO Code of Conduct for Responsible Fisheries
    • Chinese Fishery Drug Standards (NY/T 1690-2008)
    • ISO 17025 Laboratory Controls
    • GMP for Aquaculture Drugs (enforced in major APAC countries)

    Typical usage ratio

    • 20 mg – 70 mg extract per capsule, adjusted to species-specific inclusion based on fish/shrimp body mass and disease risk assessment

    Downstream process integration

    • Pre-blending with mouthfeel agents and encapsulating in gelatin or HPMC shells during capsule filling operations

    Final product types

    • Powder-filled oral capsules for ornamental fish care
    • Preventive medicinal capsules for shrimp hatcheries
    • Aquaculture health management kits
    • Capsulated supplements for high-value finfish farming

    Free Quote

    Competitive Paridis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Paridis Rhizoma Veterinary Grade API: Practical Insights from the Manufacturer’s Floor

    Rooted in Practice: Our Approach to Paridis Rhizoma API

    Producing Paridis Rhizoma Veterinary Grade API means more than refining raw material into a white powder. Sitting in conference rooms doesn’t bring out the subtle, green-tinged aromas of this mountain herb. Our engineers and plant crews see and touch differences that matter—soil clings differently in each shipment, and the scent in each batch varies with the season and elevation. Experience shows that the finest extract draws from rhizomes matured in high-altitude fields, not those hurried up in monocultures, and it makes a difference in veterinary labs and on farms where real cases play out. The big reason veterinarians want this product in tablet, injection, capsule, powder, granule, premix, or solution form comes down to the solid backbone it gives health management, especially in livestock stress seasons.

    Specifications Shaped by Daily Demands

    Years on the processing line teach that clients rely on consistent quality, not just because standards say so, but because animals react fast to changes. Our production runs feature clearly defined model grades, from API-PRD-VT-100 for refined powder, up to API-PRD-VT-500 for concentrated injectable stock. Finely calibrated particle sizing comes from a blend of traditional sieving and newer micronization. Every final batch undergoes HPLC testing—our crew watches tannin and saponin content, not just as part of routine paperwork, but because a wrong spike triggers a wasted lot or an ineffective end product. None of our jobs stick to one batch size, either. Farmers and veterinary compounding labs both want flexible order quantities, so we scale reactors and packing methods daily.

    Meeting the Real Needs of Animal Health

    Field application sets veterinary APIs apart from pharmaceutical or herbal types. Cattle and swine rarely stand still for fussy feeds. An injectable must dissolve, suspend, and draw easily into a variety of gauge needles; a tablet batch needs to press with minimal friability and short dissolution times. Out in the barns, animals need the active brought into their bloodstream—not just mixed into a ration. Paridis Rhizoma has a long track record against swelling and local inflammation. Our clients don’t just cite research abstracts; they send us photos of rapid recovery and controlled outbreaks, particularly in herds seeing repeated stress injuries or seasonal foot swelling.

    Why Purity and Source Go Hand-in-Hand

    If you’ve watched the business for a decade or more, you remember the years before tight source control, when crude mixes brought residues and trace heavy metals. Our procurement team now works upstream from seedbed to harvest, dealing directly with farmers who let rhizomes mature for the right time. Small details at source echo through the process—the smell and color in the bins, the grind in the mill, the cloudiness of a dissolved batch. Over fifty percent of product failures our lab flagged in the early 2010s could be traced back to mixed or misaged rootstock. We keep the chemistry tight now, not just because regulations loom, but because animals and their owners see the outcome in every mouthful or dose.

    Diversified Forms Fit a World of Animal Treatments

    Nobody develops a one-trick product anymore. Our range fits practical treatment setups: pure API for licensed compounding, tablet-grade for standardized pill pressing, micronized powders for dosing tools, and stable granules for easy mixing into bulk feeds. Injection forms matter most in acute care, where fast delivery and immediate uptake can tip the outcome for an entire flock during a disease flare. Meanwhile, capsules sometimes travel to distant climates where stable shelf-life trumps every other factor. Our own engineers monitor feedback not just from finished product makers, but from field veterinarians whose dosing practices shape our formulation methods. People assume all Paridis APIs dissolve the same way, but anyone who’s seen a cloudy batch of solution know subtle shifts in process change everything. We design for that, so nothing recoagulates or settles mid-treatment.

    Upholding Bioactivity and Avoiding Degradation

    Bioactivity loss haunts every herbal API business. Animal health demands a compound that stays potent, not just at the moment of production but in hot barns, humid sheds, or months in transit. Fluctuations in drying, extraction pressure, or storage temperature strip away saponins and degrade polyphenols. We’ve invested in lower-temperature extraction cycles and rapid-seal packaging on the production line. Every year, our QC team analyzes retention in samples stored for three, six, or twelve months at mock farm temperatures. Products headed for liquid or premix form require another layer of protection: we fine-tune pH buffers and add desiccants to keep breakdown in check. Clients see the results in steadier performance, from the first to last portion in a barrel or bottle.

    Veterinary Applications—What Users Tell Us Works

    Long before Paridis Rhizoma became an API staple, folk remedies saw its value. These days, pragmatic veterinarians want cold, hard data. Our facility receives field summaries from partners managing injury, infection, and stress in dairy and draught animals, especially through transition periods when disease risk spikes. Swine and poultry integrators report on group treatments with powder and granule mixes, while equine facilities focus on oral pastes and injectables to manage local trauma or inflammatory responses. We hear about compliance from feed millers who layer granules into ton-sized batches—feeders won’t tolerate a dusty product that clumps, and our teams trouble-shoot every time that phone rings about mixing issues.

    Process Control: Keeping Each Batch Consistent

    You learn the value of strict process control every time a single lot strays. Our operators refer to last week’s runs before starting a new one, logging humidity and sifting yield. Shared knowledge on the floor means fast troubleshooting; one experienced shift leader can catch a faint yellow hue signaling an off-balance extract even before the instruments ping a warning. We sign off with our own badges on every drum, tested for moisture, density, and titratable saponins. These checks save headaches for everyone downstream. Finished product makers don’t want surprises—veterinarians don’t want to recalculate dosages, and farmers certainly don’t want to risk their animals’ health on a bad batch.

    Why Our API Outpaces Other Supplier Types

    Direct experience shows why veterinary-grade Paridis Rhizoma API is more than a relabel of pharma or bulk herbal product. Veterinary users require dosage precision over a wide weight range—tablet presses need consistent bulk density, while injection forms must absolutely clear sterile filtration. We control raw rhizome drying curves, particle reductions, and sieving, updating specs whenever our applied research finds a method that cuts waste or improves stability. Traders and intermediaries chase transactional margins; as actual manufacturers, we ride out every cost and QA bottleneck in-house, fielding the angry calls if quality dips. That’s why our product range evolved side-by-side with our customers’ real needs—pawing animals, open barns, large-scale mixing plants, and busy clinics.

    Lessons from Field Failures and Continuous Feedback

    Every production manager remembers the sting of a field failure. Years ago, we shipped a poorly sealed powder batch to a poultry group in midsummer; clumping ruined automated feeders, and egg production slipped. That hard lesson changed our packaging and storage guidelines. We routinely invite customer visits to the plant floor—not staged tours, but time on the intake docks and QC benches. Feedback shapes each run; a recent case saw us redesigning a granule batch to avoid bridging in small augers. No specification sheet could have predicted the on-site result—the real test lives in barns and blending rooms, not just lab notebooks.

    Environmental Considerations in the Supply Chain

    Our plant bears the responsibility for sustainable sourcing and traceable production. Overharvesting of Paridis Rhizoma does lasting harm—not just to wild stocks, but to the very families supplying our roots. For the last decade, we’ve committed to contract growing with select family plots, rotating fields to avoid soil depletion and prioritizing hand-dug harvest methods. Our drying and solvent-recovery steps now operate with lower water and energy input than those we ran ten years ago. Environmental audits have shown measurable reductions in waste effluent, and local community monitors keep us ‘on the level’ about every truckload. These changes didn’t happen by accident; they followed from customer questions, government rules, and our own sense of what keeps this industry healthy for the long run.

    Practical Matters in Blending and Formulation

    Every downstream user faces practical headaches—from tablets that crumble, to powders that absorb humidity and clog dispensers, to solutions that separate out on the shelf. Our process engineers adjust granule hardness, add dust-binding steps, and test each form in simulated barn conditions. Oral pastes demand a fine balance of mouthfeel and dispersion; premix powders need a low static charge to avoid sticking in mixing blades. Each modification trickles back to the initial extract—higher saponin isolates will impact foaming and consistency in feed, which in turn affects how animals accept dosed material.

    Staying Ahead of Regulatory Shifts

    Rules change rapidly, country by country. We track new guidance in veterinary drug listings, feed ingredient registrations, and lot-level traceability. Our documentation comes ready for rapid audit; our plant software syncs lot numbers from source farm to final drum. Several years ago, a new import regulation in one market forced a quick pivot: we traced every rhizome lot, updated labels, and added on-site scannable codes. Our compliance team meets weekly to update MSDS sheets, batch records, and recall protocols, because tomorrow’s market never precisely follows today’s. Direct manufacturing experience convinces us that quick adaptation—without losing control over source and process—beats chasing rulebooks after the fact.

    Dealing with Misconceptions in the Market

    Much of the market still confuses veterinary grade with off-the-shelf herbal powder or pharma leftovers. Well-meaning but unproven products cause dosing disasters and legal headaches. We routinely send out technical bulletins and sponsor training for buyers, vets, and farm nutritionists to clear up myths. True API grade tracks every input, verifies active content at every handoff, and undergoes stability tracking for forms meant to survive transport, storage, and practical field use. Years of seeing underperforming copycat products makes us believe education remains as important as QC testing. Those who skip steps in the name of quick profits do long-term damage to animal health and the market’s reputation.

    Manufacturing Realities and Frontline Requests

    Frontline users bring unexpected requests—injectable forms with longer shelf-time, granules that resist breakdown in moist air, capsules with guaranteed slow-release curves for large flocks. We track these needs closely, refining coating methods or tweaking excipient blends. Feedback runs directly from farm visits into our next pilot batch. Diversifying the product line—from injectable concentrates for emergency outbreaks to microgranules for stable premix—comes from close relationships with professionals facing unpredictable conditions. Our improvements grow from these real-world partnerships, not distant market research.

    The Downstream Ripple: How API Quality Changes Outcomes

    Real impact shows up where batches are blended for hundreds or thousands of animals, and farms bet seasonal success on the blend. One poor batch—sluggish dissolution, bland taste, degraded actives—undercuts every investment made in livestock health. We review field reports each quarter, correlating client-completed trials with in-house stability test results. Where problems surface, root cause analysis leads us to adjust process parameters, shift raw material lots, or update staff training. It’s less about chasing paperwork, more about knowing every drum carries a living outcome in barns and animal clinics.

    Continuous Improvement Driven by Real Evidence

    Year after year, field evidence shapes our methodologies. Veterinary clinics, integrators, and nutritionists ask for cleaner, safer, and more effective Paridis Rhizoma forms. We respond with incremental changes—heat-stable packaging, more precise dosing, tighter active-content variations. We routinely run controlled comparison batches when user groups report variable animal response. Our plant shifts SOPs to match what works best, not just for yield, but for on-the-ground results. Staff training reflects this spirit of practical inquiry; new hires learn both the plant layout and the needs of the end-users their work supports.

    Final Perspective—Built on Real Manufacturing, Not Middleman Sales

    Paridis Rhizoma Veterinary Grade API represents the meeting point of long-standing manufacturing care, flexible production, and direct field experience. We don’t answer to distant distribution networks or slip generic powder into new packages. Every new improvement, batch, and form reflects lessons from real use—dosing in barns, blending at nutrition mills, clinical use during outbreaks, and tough regulatory changes. We build value into each lot before it ever ships, because every day on the factory floor proves that stable, potent, well-processed API saves labor and supports real animal health. That’s not just manufacturing pride—it’s practical necessity.

    Top